NEW YORK, USA, June 09, 2026 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Personalized Cancer Medicine Market By Type (Personalized Medicine Diagnostics and Personalized Medicine Therapeutics), By End-User (Clinics, Hospitals, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034” in its research database.
“According to the latest research study, the global personalized cancer medicine market size was valued at around USD 95.23 billion in 2024. The market is expected to grow at a CAGR of 12.51% and is anticipated to reach a value of USD 279.87 billion by 2034.”
Get a Free Sample PDF of this Research Report for more Insights - https://www.zionmarketresearch.com/sample/personalized-cancer-medicine-market
(Before you plan to buy, sample reports are a great option to examine our in-depth studies or reports)
Personalized Cancer Medicine Market Overview:
Personalized cancer medicine is a customized approach toward detecting, treating, and managing cancer. It deals with developing diagnostic tools and medical therapies that are unique to a cancer patient’s medical needs. Precision medicine has emerged as a popular form of healthcare since it offers a higher success rate compared to conventional medical procedures. The complexity of cancer disease has further encouraged advancements in personalized cancer medicine. In oncology, personalized care focuses on targeting specific molecular alterations that drive cancer progression.
During the forecast period, demand for personalized cancer medicine is projected to grow due to the rising prevalence of cancer. Increased research-based investments and expansion of the healthcare sector will further influence market growth. However, the high cost of treatment, lack of skilled workforce, and absence of supportive infrastructure may limit market growth trends in the coming years.
Report Scope:
| Report Attribute | Report Details |
| Market Size in 2024 | USD 95.23 Billion |
| Market Forecast in 2034 | USD 279.87 Billion |
| Growth Rate | CAGR of 12.51% |
| Base Year | 2024 |
| Forecast Years | 2025- 2034 |
| Key Companies Covered | AstraZeneca, Novartis, Bristol Myers Squibb, Illumina, Guardant Health, Caris Life Sciences, NeoGenomics Laboratories, Roche, Foundation Medicine, Pfizer, Tempus, GRAIL, Johnson & Johnson, Merck & Co., Exact Sciences, and others. |
| Segments Covered | By Type, By End-User, and By Region |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
| Customization Scope | Avail customized purchase options to meet your exact research needs. |
Directly Purchase a Copy of the Report | Quick Delivery Available - https://www.zionmarketresearch.com/buynow/su/personalized-cancer-medicine-market
Key Insights
- As per the analysis, the personalized cancer medicine market share is likely to grow at a CAGR of around 12.51% between 2025 and 2034.
- The personalized cancer medicine market size was worth around $95.23 billion in 2024 and is estimated to hit approximately $279.87 billion by 2034. Due to a variety of driving factors, the market is predicted to rise at a significant rate.
- The market is driven by the growing prevalence of cancer worldwide.
- Based on the type, the personalized medicine therapeutics segment dominated the market with more than 75% share in 2024 as it continues to lead due to demand for targeted therapies.
- Based on the end-user, the hospitals segment dominated with around 66% share owing to advanced infrastructure and high patient volume.
- Based on region, the Asia-Pacific dominated the global market driven by rising cancer prevalence, infrastructure development, and regulatory support.
Personalized Cancer Medicine Market: Dynamics
Growth Drivers
How will the rising prevalence of cancer drive demand in the personalized cancer medicine market?
The global personalized cancer medicine market is expected to be driven by the growing prevalence of cancer worldwide. According to relevant health data, a significant portion of the population will be diagnosed with cancer in their lifetime. It remains a leading cause of death globally. The most common types include colorectal, breast, and lung cancer. Lifestyle, environmental, and genetic factors contribute prominently to cancer incidence. Personalized cancer medicine has shown better results in treating and managing cancer as compared to conventional treatments, subsequently driving market demand.
Shift toward targeted approach and immunotherapy to work in favor of the industry players
Chemotherapy, the traditionally used technique for cancer treatment, has several side effects and shows limited success for certain types of cancer. This has resulted in greater demand for a targeted approach and immunotherapy. Personalized medicine deals with tumor-agnostic treatments and mutation-specific drugs since they cause reduced side effects and an elevated response rate. The global personalized cancer medicine market will benefit from the ongoing research & development (R&D) in targeted therapies for improved results.
Restraints
Why will cost barriers limit the expansion of the personalized cancer medicine market?
The global personalized cancer medicine industry is expected to be restricted due to cost barriers. Personalized therapies are expensive medical procedures since they deal with developing patient-centric medical care programs. The average cost of personalized cancer medicine can range significantly per patient, depending on the cancer stage and the patient's overall health, along with other factors. Economic uncertainty worldwide is projected to affect market adoption trends in the coming years.
Opportunities
Use of Artificial Intelligence (AI) in personalized cancer medicine to offer new growth opportunities
The global personalized cancer medicine market is anticipated to generate growth opportunities due to the rising use of Artificial Intelligence. Advancements in AI-powered platforms help enhance genomic testing and advance cancer research. Rising advancements in AI and Machine Learning (ML) will prove beneficial in the long run for drug testing and precision diagnostics.
Which emerging fields will present expansion possibilities to the personalized cancer medicine market players?
Emerging fields such as spatial omics and companion diagnostics (CDx) testing are expected to open new doors for market growth. Spatial omics utilizes next-generation technologies to map molecular information on tissue samples, thus revealing the place of interaction of cancer cells and immune cells. These systems are designed to provide information about cancer on a deeper level, thus facilitating improvements in medical treatments.
Challenges
Lack of infrastructure and a skilled workforce to challenge market growth over the forecast period
The global personalized cancer medicine industry is expected to be challenged by the lack of supportive infrastructure and a skilled workforce. Personalized cancer treatment is facilitated by advanced oncology centers and diagnostic labs. It also requires the input of skilled experts. In addition, the absence of standard reimbursement policies concerning personalized cancer care may further affect business revenue in the coming years.
Browse the full “Personalized Cancer Medicine Market By Type (Personalized Medicine Diagnostics and Personalized Medicine Therapeutics), By End-User (Clinics, Hospitals, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Size, Share, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034” Report at https://www.zionmarketresearch.com/report/personalized-cancer-medicine-market
Personalized Cancer Medicine Market: Segmentation
The personalized cancer medicine market is segmented by type, end-user, and region.
Based on Type, the personalized cancer medicine market is divided into personalized medicine diagnostics, personalized medicine therapeutics, and others. The personalized medicine therapeutics segment was the most dominant in 2024, capturing more than 75% of the global revenue due to the higher prevalence of cancer, increased demand for value-based healthcare, and technological advancements in targeted therapies. This dominance drives the market by offering mutation-specific and tumor-agnostic treatments that provide better outcomes with fewer side effects compared to traditional methods. It supports sustained growth through continuous R&D in immunotherapy and precision drugs. The diagnostics segment serves as a strong second, enabling accurate molecular profiling essential for tailoring therapies and improving overall treatment efficacy across patient populations.
Based on End-User, the personalized cancer medicine market is divided into clinics, hospitals, and others. The hospitals segment was the most dominant, accounting for around 66% share in 2024, propelled by the expansion of healthcare infrastructure, improved reimbursement policies, and rising consumer awareness. Hospitals provide comprehensive facilities for advanced diagnostics and complex therapies, making them central hubs for personalized cancer care and driving consistent high-volume demand. This segment propels market growth by integrating cutting-edge technologies and multidisciplinary teams. The clinics segment holds the second position, offering accessible and specialized outpatient services that complement hospital care and broaden market reach.
Regional Scope:
Why will Asia-Pacific continue to dominate the global market during the projection period?
The global personalized cancer medicine market is expected to witness strong performance from the Asia-Pacific region during the forecast period. Rising prevalence of cancer, infrastructure development, and regulatory support will aid regional growth. Moreover, the introduction of domestically developed personalized cancer medicines and devices will allow accelerated growth across the Asia-Pacific. Countries like China, Japan, and India are key contributors to expanding healthcare investments and growing patient awareness. Rapid urbanization and increasing access to advanced diagnostics further bolster demand in the region.
North America maintains a leading position supported by robust healthcare infrastructure, heavy investments in cancer research by healthtech companies, and integration of AI in care protocols. The United States drives much of the innovation and adoption.
Europe benefits from strong regulatory frameworks, advanced research institutions, and a focus on precision oncology in countries such as Germany, the UK, and France. Latin America and the Middle East & Africa are expected to experience steady expansion driven by improving healthcare access and rising cancer awareness.
Request For Customization on This Report as Per Your Requirements - https://www.zionmarketresearch.com/custom/10609
Personalized Cancer Medicine Market: Competitive Landscape
The report contains qualitative and quantitative research on the global personalized cancer medicine market, as well as detailed insights and development strategies employed by the leading competitors.
Some of the leading players in the global personalized cancer medicine market include;
- AstraZeneca
- Novartis
- Bristol Myers Squibb
- Illumina
- Guardant Health
- Caris Life Sciences
- NeoGenomics Laboratories
- Roche
- Foundation Medicine
- Pfizer
- Tempus
- GRAIL
- Johnson & Johnson
- Merck & Co.
- Exact Sciences
The global personalized cancer medicine market is segmented as follows:
By Type
- Personalized Medicine Diagnostics
- Personalized Medicine Therapeutics
By End-User
- Clinics
- Hospitals
- Others
By Region
- North America
- The U.S.
- Canada
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Southeast Asia
- Rest of Southeast Asia
- The Middle East & Africa
- GCC
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Request Free Brochure of the Global Personalized Cancer Medicine Market @ https://www.zionmarketresearch.com/requestbrochure/personalized-cancer-medicine-market
Key Questions Answered in This Report:
- What is personalized cancer medicine?
- What are the key growth drivers of the personalized cancer medicine Market?
- What will be the value of the personalized cancer medicine market during 2025-2034?
- What will be the CAGR value of the personalized cancer medicine market during 2025-2034?
- What are the major challenges restraining the growth of the personalized cancer medicine market?
- What are the emerging trends and innovations impacting the personalized cancer medicine market?
- How has the global personalized cancer medicine market performed so far and how will it perform in the coming years?
- Which region will contribute notably towards the personalized cancer medicine market value?
- Which are the major players leveraging the personalized cancer medicine market growth?
- What can be expected from the global personalized cancer medicine market report?
What are the latest key trends in the personalized cancer medicine market?
Advancements in cell and gene therapies
Ongoing developments in cell and gene therapies are expected to encourage the adoption of personalized cancer medicine in mainstream oncology. These advancements will promote the development of cutting-edge targeted therapies for cancer.
Focus on early detection
A prominent trend in the personalized cancer treatment industry is the use of technology to detect cancer in early stages. Liquid biopsies have emerged as an effective tool promoting early detection, subsequently improving the success rate for cancer treatment.
Browse Other Related Research Reports
- Endometrial Cancer Market By Type of Cancer (Uterine Sarcomas, Endometrial Carcinoma, and Others), By Type of Therapy (Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapies, and Others), By Diagnosis Method (Pelvic Ultrasound, Biopsy, CT Scan Hysteroscopy, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
- Acetylcysteine Market By Type (Spray, Tracheal Drip, and Tablet), By Application (Personal Care, Dietary Supplements, Pharmaceuticals, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
- Cancer Monoclonal Antibodies Market By Type (Murine, Chimeric, Human, and Humanized), By Application (Lung Cancer, Blood Cancer, Melanoma, Colorectal Cancer, Breast Cancer, Liver Cancer, and Others), By End-User (Research Institutions, Hospitals, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
- Optical Genome Mapping Market By Product and Service (Instruments, Consumables, Software and Data Analysis Tools, Services), By Application (Cancer Research and Oncology, Constitutional Genetics and Rare Disease Diagnosis, Infectious Disease Research, Agricultural Genomics, Drug Discovery and Development), By End User (Hospitals and Clinical Laboratories, Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Forensic Laboratories, Contract Research Organizations), By Technology (Nanochannel-Based Optical Mapping, Fluorescence-Based Optical Mapping, Single-Molecule Optical Mapping), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
- Radiopharmaceutical CDMO Market By Service Type (Contract Manufacturing, Analytical & Quality Control Services, Contract Development and Packaging, Labeling & Logistics), By Radioisotope Type (Fluorine-18, Gallium-68, Technetium-99m, Lutetium-177, Actinium-225 and Others), By Therapeutic Area (Oncology, Neurology, Cardiology and Others), By Application (Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals) and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
About Zion Market Research:
Zion Market Research is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Zion Market Research are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Contact Us:
Zion Market Research
USA/Canada Toll Free: 1 (855) 465-4651 | Newark: 1 (302) 444-0166
India: +91 7768 006 007 | +91 7768 006 008
Email: sales@zionmarketresearch.com | Web: https://www.zionmarketresearch.com/
Follow Us on - LinkedIn | X | Facebook | Pinterest | YouTube
